--- title: Reid Hoffman leaves Microsoft board to go 'founder mode'... description: Reid Hoffman is stepping down from Microsoft's board of directors after nearly a decade to focus full-time on Manus, his AI-powered drug discovery startup.... canonical: https://daily.dev/posts/reid-hoffman-leaves-microsoft-board-to-go-founder-mode-with-ai-drug-startup-manus-ss1qm5mip twitter:card: summary_large_image twitter:site: @dailydotdev og:type: website og:site_name: daily.dev og:title: Reid Hoffman leaves Microsoft board to go 'founder mode' with AI drug startup Manus | daily.dev og:description: Reid Hoffman is stepping down from Microsoft's board of directors after nearly a decade to focus full-time on Manus, his AI-powered drug discovery startup.... og:url: https://daily.dev/posts/reid-hoffman-leaves-microsoft-board-to-go-founder-mode-with-ai-drug-startup-manus-ss1qm5mip og:image: https://api.daily.dev/og/posts/SS1Qm5MIP.png og:image:alt: Reid Hoffman leaves Microsoft board to go 'founder mode' with AI drug startup Manus og:image:width: 1200 og:image:height: 630 og:locale: en --- > ## Documentation Index > Fetch the complete documentation index at: https://daily.dev/llms.txt > Use this file to discover all available pages before exploring further. # Reid Hoffman leaves Microsoft board to go 'founder mode' with AI drug startup Manus **[The Next Web](https://daily.dev/sources/tnw)** · 2 min read · 0 upvotes · 1 comments ## Summary Reid Hoffman is stepping down from Microsoft's board of directors after nearly a decade to focus full-time on Manus, his AI-powered drug discovery startup. Hoffman joined Microsoft's board in 2016 following the $26.2 billion LinkedIn acquisition and was present during pivotal AI investments including the first $1 billion into OpenAI. Manus, co-founded with Pulitzer Prize-winning physician Dr. Siddhartha Mukherjee, has raised over $50 million in seed funding backed by General Catalyst. Hoffman describes the company's approach as 'Move 37' AI — systems capable of surpassing human creativity in chemistry to discover novel cancer-fighting compounds. The move comes as AI drug discovery intensifies, with ByteDance's Anew Labs and Google DeepMind's Isomorphic Labs also advancing AI-designed therapies. ## Full article daily.dev links to this article rather than hosting it. Read it at the original source: --- Tags: [#microsoft](https://daily.dev/tags/microsoft), [#openai](https://daily.dev/tags/openai) [View this post on daily.dev](https://daily.dev/posts/reid-hoffman-leaves-microsoft-board-to-go-founder-mode-with-ai-drug-startup-manus-ss1qm5mip) ```json {"@context":"https://schema.org","@graph":[{"@type":"Organization","@id":"https://daily.dev/#organization","name":"daily.dev","url":"https://daily.dev","logo":{"@type":"ImageObject","url":"https://daily.dev/apple-touch-icon.png","width":180,"height":180},"sameAs":["https://twitter.com/dailydotdev","https://github.com/dailydotdev","https://www.linkedin.com/company/daily-dev-ltd"]},{"@type":"WebSite","@id":"https://daily.dev/#website","url":"https://daily.dev","name":"daily.dev","publisher":{"@id":"https://daily.dev/#organization"},"potentialAction":{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https://daily.dev/search?q={search_term_string}"},"query-input":"required name=search_term_string"}}]} {"@context":"https://schema.org","@type":"TechArticle","headline":"Reid Hoffman leaves Microsoft board to go 'founder mode' with AI drug startup Manus","url":"https://daily.dev/posts/reid-hoffman-leaves-microsoft-board-to-go-founder-mode-with-ai-drug-startup-manus-ss1qm5mip","mainEntityOfPage":{"@type":"WebPage","@id":"https://daily.dev/posts/reid-hoffman-leaves-microsoft-board-to-go-founder-mode-with-ai-drug-startup-manus-ss1qm5mip"},"datePublished":"2026-06-06T11:07:11.768Z","dateModified":"2026-06-06T11:07:31.007Z","description":"Reid Hoffman is stepping down from Microsoft's board of directors after nearly a decade to focus full-time on Manus, his AI-powered drug discovery startup....","image":"https://media.daily.dev/image/upload/f_auto,q_auto/v1/posts/636984ec03b9ae7bef4d5cc34d79dba0?_a=AQAEuop","thumbnailUrl":"https://media.daily.dev/image/upload/f_auto,q_auto/v1/posts/636984ec03b9ae7bef4d5cc34d79dba0?_a=AQAEuop","isAccessibleForFree":true,"articleSection":"The Next Web","inLanguage":"en","publisher":{"@type":"Organization","name":"daily.dev","url":"https://daily.dev","logo":{"@type":"ImageObject","url":"https://daily.dev/apple-touch-icon.png","width":180,"height":180}},"author":{"@type":"Organization","name":"The Next Web","logo":"https://media.daily.dev/image/upload/t_logo,f_auto/v1/logos/tnw","url":"https://daily.dev/sources/tnw"},"commentCount":1,"discussionUrl":"https://daily.dev/posts/reid-hoffman-leaves-microsoft-board-to-go-founder-mode-with-ai-drug-startup-manus-ss1qm5mip","interactionStatistic":[{"@type":"InteractionCounter","interactionType":{"@type":"LikeAction"},"userInteractionCount":0},{"@type":"InteractionCounter","interactionType":{"@type":"CommentAction"},"userInteractionCount":1}],"keywords":"microsoft,openai","timeRequired":"PT2M"} {"@context":"https://schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https://daily.dev"},{"@type":"ListItem","position":2,"name":"The Next Web","item":"https://daily.dev/sources/tnw"},{"@type":"ListItem","position":3,"name":"Reid Hoffman leaves Microsoft board to go 'founder mode' with AI drug startup Manus"}]} ```